Evaluation of safety and efficacy of transjugular liver biopsy in allogeneic hematopoietic stem cell transplant recipients

Taku Kikuchi; Takehiko Mori; Yuya Koda; Masuho Saburi; Sumiko Kohashi; Takaaki Toyama; Jun Kato; Subaru Hashimoto; Masayuki Nakatsuka; Hirotoshi Ebinuma; Shinichiro Okamoto

Evaluation of safety and efficacy of transjugular liver biopsy in allogeneic hematopoietic stem cell transplant recipients

Taku Kikuchi, Takehiko Mori, Yuya Koda, Masuho Saburi, Sumiko Kohashi, Takaaki Toyama, Jun Kato, Subaru Hashimoto, Masayuki Nakatsuka, Hirotoshi Ebinuma, Shinichiro Okamoto

Department of Internal Medicine (Hematology)

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

We retrospectively evaluated the safety and utility of transjugular liver biopsy (TJLB) in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Ten patients underwent HSCT between 1991 and 2013. Eight patients with thrombocytopenia received platelet transfusions before and/or during TJLB. No complications associated with TJLB were observed. Samples adequate for a pathological diagnosis were obtained in 9 of the 10 patients, and the diagnoses made by TJLB were graft-versus-host-disease in eight patients and non-specific hepatitis in one. These results suggest that TJLB is a safe and effective procedure for the evaluation of liver injury in HSCT recipients.

Original language	English
Pages (from-to)	2320-2323
Number of pages	4
Journal	[Rinshō ketsueki] The Japanese journal of clinical hematology
Volume	55
Issue number	11
Publication status	Published - 2014 Nov 1

ASJC Scopus subject areas

Medicine(all)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{c7bab05e9cf8449a921bedf1e4fcf5b1,

title = "Evaluation of safety and efficacy of transjugular liver biopsy in allogeneic hematopoietic stem cell transplant recipients",

abstract = "We retrospectively evaluated the safety and utility of transjugular liver biopsy (TJLB) in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Ten patients underwent HSCT between 1991 and 2013. Eight patients with thrombocytopenia received platelet transfusions before and/or during TJLB. No complications associated with TJLB were observed. Samples adequate for a pathological diagnosis were obtained in 9 of the 10 patients, and the diagnoses made by TJLB were graft-versus-host-disease in eight patients and non-specific hepatitis in one. These results suggest that TJLB is a safe and effective procedure for the evaluation of liver injury in HSCT recipients. ",

author = "Taku Kikuchi and Takehiko Mori and Yuya Koda and Masuho Saburi and Sumiko Kohashi and Takaaki Toyama and Jun Kato and Subaru Hashimoto and Masayuki Nakatsuka and Hirotoshi Ebinuma and Shinichiro Okamoto",

year = "2014",

month = nov,

day = "1",

language = "English",

volume = "55",

pages = "2320--2323",

journal = "[Rinshō ketsueki] The Japanese journal of clinical hematology",

issn = "0485-1439",

publisher = "Nihon Rinsho Ketsueki Gakkai/Japan Society of Clinical Hematology",

number = "11",

}

TY - JOUR

T1 - Evaluation of safety and efficacy of transjugular liver biopsy in allogeneic hematopoietic stem cell transplant recipients

AU - Kikuchi, Taku

AU - Mori, Takehiko

AU - Koda, Yuya

AU - Saburi, Masuho

AU - Kohashi, Sumiko

AU - Toyama, Takaaki

AU - Kato, Jun

AU - Hashimoto, Subaru

AU - Nakatsuka, Masayuki

AU - Ebinuma, Hirotoshi

AU - Okamoto, Shinichiro

PY - 2014/11/1

Y1 - 2014/11/1

N2 - We retrospectively evaluated the safety and utility of transjugular liver biopsy (TJLB) in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Ten patients underwent HSCT between 1991 and 2013. Eight patients with thrombocytopenia received platelet transfusions before and/or during TJLB. No complications associated with TJLB were observed. Samples adequate for a pathological diagnosis were obtained in 9 of the 10 patients, and the diagnoses made by TJLB were graft-versus-host-disease in eight patients and non-specific hepatitis in one. These results suggest that TJLB is a safe and effective procedure for the evaluation of liver injury in HSCT recipients.

AB - We retrospectively evaluated the safety and utility of transjugular liver biopsy (TJLB) in allogeneic hematopoietic stem cell transplant (HSCT) recipients. Ten patients underwent HSCT between 1991 and 2013. Eight patients with thrombocytopenia received platelet transfusions before and/or during TJLB. No complications associated with TJLB were observed. Samples adequate for a pathological diagnosis were obtained in 9 of the 10 patients, and the diagnoses made by TJLB were graft-versus-host-disease in eight patients and non-specific hepatitis in one. These results suggest that TJLB is a safe and effective procedure for the evaluation of liver injury in HSCT recipients.

UR - http://www.scopus.com/inward/record.url?scp=84925374157&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925374157&partnerID=8YFLogxK

M3 - Article

C2 - 25501415

AN - SCOPUS:84925374157

SN - 0485-1439

VL - 55

SP - 2320

EP - 2323

JO - [Rinshō ketsueki] The Japanese journal of clinical hematology

JF - [Rinshō ketsueki] The Japanese journal of clinical hematology

IS - 11

ER -

Evaluation of safety and efficacy of transjugular liver biopsy in allogeneic hematopoietic stem cell transplant recipients

Abstract

ASJC Scopus subject areas

UN SDGs

Other files and links

Fingerprint

Cite this